CRISPR-Cas9 gene editing is an essential functional genomics tool, facilitating the cataloging of genomic variations linked to human diseases for the discovery and validation of novel drug targets.

Pharmacogenomic testing uses a patient’s genome to identify their response to a drug, forming a key part of personalized medicine.
Hundreds of clinical pharmacogenomics (PGx) tests are currently available on the market in the United States. With so many tests available, how can you determine that a test is clinically and analytically valid and holds clinical utility?
In this webinar, our expert speaker will outline the ACCE Model Project Framework as a tool for evaluating pharmacogenomic tests, describing the key considerations to take into account when implementing these tests.
You’ll learn how to select the genetic variants to be tested, choose the appropriate genotyping technology and develop laboratory procedures for sample processing and data analysis.

In this webinar, you’ll hear from two experts about their research into microbial communities and the impact of nanopore sequencing technologies on their work.

In this webinar, you’ll learn about the insights you could gain by profiling gene expression and open chromatin from the same cell simultaneously.

In this webinar, we’ll explore how integrating proteomics with systems biology sheds light on the complexities of AD pathology.

Our expert speaker will explore how the findings uncover previously unknown insights into disease biology that can help accelerate the identification of new therapeutic targets and biomarkers.